» Articles » PMID: 12097376

The Majority of Immunogenic Epitopes Generate CD4+ T Cells That Are Dependent on MHC Class II-bound Peptide-flanking Residues

Overview
Journal J Immunol
Date 2002 Jul 5
PMID 12097376
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

Peptides bind to MHC class II molecules with a defined periodicity such that the peptide-flanking residues (PFRs) P-1 and P11, which lie outside the core binding sequence (P1-P9), are solvent exposed and accessible to the TCR. Using a novel MHC class II:peptide binding assay, we defined the binding register for nine immunogenic epitopes to formally identify the flanking residues. Seven of the nine epitopes, restricted by H-2A(k), H-2A(g7), or H-2E(k), were found to generate T cells that were completely dependent on either P-1 or P11, with dependency on P-1 favored over P11. Such PFR dependency appears to be influenced by the type of amino acid exposed, in that residues that can form salt bridges or hydrogen bonds are favored over small or hydrophobic residues. Peptides containing alanine substitutions at P-1 or P11 in place of PFRs that mediate dependency were considerably less immunogenic and mediated a substantially reduced in vitro recall response to the native protein, inferring that PFR recognition increases immunogenicity. Our data suggest that PFR recognition is a common event characteristic of all MHC class II-restricted T cell responses. This key feature, which is not shared by MHC class I-restricted responses, may underlie the broad functional diversity displayed by MHC class II-restricted T cells.

Citing Articles

Geometric deep learning improves generalizability of MHC-bound peptide predictions.

Marzella D, Crocioni G, Radusinovic T, Lepikhov D, Severin H, Bodor D Commun Biol. 2024; 7(1):1661.

PMID: 39702482 PMC: 11659464. DOI: 10.1038/s42003-024-07292-1.


Energy landscapes of peptide-MHC binding.

Collesano L, Luksza M, Lassig M PLoS Comput Biol. 2024; 20(9):e1012380.

PMID: 39226310 PMC: 11398667. DOI: 10.1371/journal.pcbi.1012380.


Expanding the MAPPs Assay to Accommodate MHC-II Pan Receptors for Improved Predictability of Potential T Cell Epitopes.

Hartman K, Steiner G, Siegel M, Looney C, Hickling T, Bray-French K Biology (Basel). 2023; 12(9).

PMID: 37759665 PMC: 10525474. DOI: 10.3390/biology12091265.


Insight into Cancer Immunity: MHCs, Immune Cells and Commensal Microbiota.

Wen M, Li Y, Qin X, Qin B, Wang Q Cells. 2023; 12(14).

PMID: 37508545 PMC: 10378520. DOI: 10.3390/cells12141882.


Induction of cancer neoantigens facilitates development of clinically relevant models for the study of pancreatic cancer immunobiology.

Panni U, Chen M, Zhang F, Cullinan D, Li L, James C Cancer Immunol Immunother. 2023; 72(8):2813-2827.

PMID: 37179276 PMC: 10361914. DOI: 10.1007/s00262-023-03463-x.